SS-31
A mitochondria-targeting peptide studied for cellular energy, cardiac function, and age-related decline.
A mitochondrial-support compound studied for cellular energy, cognition, and neuroprotection.
In the literature, Methylene Blue appears most often in work focused on cognition, energy and mitochondria. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Methylene Blue is catalogued here under tablets. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A mitochondria-targeting peptide studied for cellular energy, cardiac function, and age-related decline.
An AMPK activator studied as an exercise mimetic for endurance and metabolic research.
A neuropeptide preparation studied for neuroprotection, cognitive function, and recovery after brain injury.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.